852874-61-4 Usage
General Description
"(S)-1-Methylpyrrolidin-3-amine hydrochloride is a chemical compound known for its application in the field of pharmaceuticals, particularly in the synthesis of drug molecules. This chemical, characterized by its chiral nature, possesses a hydrochloride functional group making it a salt, hence facilitating its dissolution in water or other polar solvents. As a result, it is often used as a valuable intermediate in chemical reactions. It belongs to the family of Pyyrolidines, which are cyclic organic compounds containing a five-membered ring with one nitrogen atom. The molecular structure of (S)-1-Methylpyrrolidin-3-amine hydrochloride, including the relative configuration of its stereocentre, is specifically designed to ensure its effectiveness in carrying out its role in the synthesis process.
Check Digit Verification of cas no
The CAS Registry Mumber 852874-61-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,2,8,7 and 4 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 852874-61:
(8*8)+(7*5)+(6*2)+(5*8)+(4*7)+(3*4)+(2*6)+(1*1)=204
204 % 10 = 4
So 852874-61-4 is a valid CAS Registry Number.
852874-61-4Relevant articles and documents
FUSED RING COMPOUND FOR USE AS MINERALOCORTICOID RECEPTOR ANTAGONIST
-
Paragraph 0155, (2013/07/19)
The present invention belongs to the technical field of medicine, relating in particular to: a fused ring compound as represented by Formula (I) for use as a mineralocorticoid receptor antagonist, a pharmaceutically acceptable salt thereof, and an isomer thereof; a preparation method for these compounds; a pharmaceutical preparation containing these compounds; and an application of these compounds, the pharmaceutically acceptable salt thereof, or the isomers thereof in the preparation of medicants for the treatment and/or prevention of kidney injury, cardiovascular diseases such as hypertension, and/or endocrine disease. The definitions of X, Y1, Y2, Y3, R1, R2a,R2b , R3a , R3b, R4, Cy and n are as presented in the description.
PYRAZOLOPYRIMIDINES
-
Page/Page column 98, (2010/02/12)
This invention relates to compounds of formula (I).
